BioInnovation Capital
Venture capitalCambridge · 1 people tracked
Find your way into BioInnovation Capital
Sign up to see every warm intro you have to BioInnovation Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BioInnovation Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Fund manager profile
BioInnovation Capital is a venture fund manager based in Cambridge. SEC filings show 1 venture fund on record, most recently BioInnovation Capital I LP filed February 2017.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 1 people
from public directoriesWhat they invest in
from 2 of 2 portfolio companiesBiotech ×2
HQs:United States×2
Investments · 2 tracked
founders shown can be your intro pathBy year:2018 · 12015 · 12 dated
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Frequently asked questions
- Where is BioInnovation Capital located?
- BioInnovation Capital is headquartered in Cambridge, US.
Co-investors · 3
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
NewView Capital is a growth-stage investment firm providing flexible capital to high-potential companies in enterprise software and fintech, supporting them with operational guidance and network connections.
Domain Associates is a venture capital firm founded in 1985 that invests in life sciences companies. The firm operates as a limited liability company.
Firms observed investing alongside BioInnovation Capital, from public investor directories. Shared companies are the overlap with BioInnovation Capital's recorded portfolio.

